Monday, July 9, 2018

Pharmacovigilance Market Comprehensive Research Study and Strong Growth in Future 2023


Pharmacovigilance Market
The global pharmacovigilance market is growing significantly due to increasing concern for drug safety, increasing incidences of adverse drug reactions and toxicity, and high patient compliance for drug usage. In addition, government and non-government organizations are actively involved in determining drug safety and efficacy, which in turn is supporting growth of global pharmacovigilance market.


According to the studies conducted by WHO in developed countries, approximately 5% of hospitalized patients are admitted in the hospitals due to adverse drug reaction, and 6-10% of these patients would suffer from serious adverse drug reactions. Pharmaceutical and biotechnology companies are actively involved in the development of new drugs; this creates an increased demand for pharmacovigillance.


Geographically, North America leads the global pharmacovigilance market due to high incidences of adverse drug reactions and high regulatory compliance for pharmacovigilance. In addition, presence of a large number of pharmaceutical and biotechnology companies is fueling the growth of the North American pharmacovigilance market.

Asia-Pacific is the fastest growing region in the global pharmacovigilance market due to increasing concern for drug safety and efficacy, increasing incidences of adverse drug reactions and toxicity, and increasing number of pharmaceuticals and biotechnology companies. Moreover, the pharmacovigilance market is growing rapidly due high growth of generic drugs market in emerging economies, such as India and China.


Some of the major players operating in the global pharmacovigilance market are Sanofi, Cognizant Technology Solutions, Accenture, Wipro Limited, F. Hoffmann-La Roche Ltd., ICON plc, Clinquest Group B.V., Pfizer Inc., PAREXEL International Corporation, Novartis AG, iGATE Corporation, GlaxoSmithKline, and Bristol-Myers Squibb Company.

Posted by at No comments:
Labels: , ,

Sunday, July 8, 2018

Biosimulation Technology Market - Size, Application, Market share, Global Trends and Forecast to 2023


Biosimulation Technology Market
The global biosimulation market is growing significantly due to technological advancements and increasing research and development investment in the pharmaceutical and biotechnology industries. Low success rate of drug approval and emerging software applications of biosimulation technology are creating ample opportunities for the global biosimulation technology market to grow at a significant rate in the forecasted period.
According to Tufts Centre for the Study of Drug Development, an academic, non-profit research group at Tufts University, in the U.S., out of 1,000 compounds tested only one makes it to human clinical trials, and out of five such compounds only one gets approved. Biosimulation technology overcomes these limitations by simulating biological systems through software models and increasing predictability in early stages of drug development; hence, saving time and money in drug development process.
Biosimulation technology market can be categorized on the basis of applications, end-users, and product types. Based on applications, the biosimulation technology market can be categorized as drug development, drug discovery, and others. Based on end-users, biosimulation technology market can be categorized as pharmaceutical and biotechnology companies, academic institutes and research laboratories, contract research organizations, and others. Pharmaceutical and biotechnology companies lead the biosimulation technology market.
Some of the factors driving the growth of the global biosimulation technology market are increasing research and development expenditures, increasing investment in biosimulation training and education programs, technological advancements, increasing focus on reducing drug discovery and development cost, and increasing healthcare expenditure.
Geographically, North America will be leading the global biosimulation technology market in the coming years due to technological advancements, growth in biosimilars and biologics market, high healthcare expenditure, and presence of a large number of pharmaceuticals and biotechnology companies. In addition, the U.S. Food and Drug Administration (FDA), strongly recommends simulation process in drug discovery and development; hence, fueling the growth of biosimulation technology market in North America. Europe is the fastest growing region in the global biosimulation technology market. The major reasons for the fastest growth in the region are high healthcare expenditure and increasing research and development activities.
Some of the major players operating in the global biosimulation technology market Dassault Systemes SA, Simulation Plus Inc., Certara USA, Inc., Advanced Chemistry Development, Inc., In Silico Biosciences, Inc., Chemical Computing Group, Inc., Physiomics PLC., Rhenovia Pharma Ltd., Genedata AG, Entelos Holding Corporation, Leadscope, Inc., and Schrodinger Inc. among others.

Posted by at No comments:
Labels: , ,

Thursday, July 5, 2018

Medical Waste Management Market Trends in 2018 —What industry insiders tell Us about the future forecast 2023


Medical Waste Management Market 
Medical waste refers to the waste originated within medical amenities such as hospitals, clinics, veterinary hospitals/clinics, dental practices, physician's offices, laboratories, blood banks and research and development centers (R&D) related to healthcare.

The medical waste management program is critical for the public health, environment, and sanitation. Unlike municipal waste treatment the medical waste management involves various stages of waste management, such as accumulation, generation, storage, handling, treatment, transport, and disposal.


Based on the different business sector the global medical waste management market can be bifurcated as:
·         Hospital Waste Management
o    Anatomical Waste Management
o    Regular Medical Waste Management
·         Pharmaceutical Waste Management
o    Clinical Trial Waste Management
o    Manufacturing Waste Management

On the basis of various services under medical waste treatment the global medical waste treatment market can be classified as:
·         Collection, Transportation, and Storage
·         Waste Treatment
·         Disposal/Recycling

On the basis of waste treatment technology the global medical waste treatment market can be segmented as:
·         Mechanical
·         Chemical
·         Thermal
·         Others

On the basis of waste generator the global medical waste treatment market can be further segmented as:
·         Large Quantity Generator
·         Small Quantity Generator

On the bases of various type of waste the global waste treatment market can be further segmented as:
·         Biomedical waste management
·         Cytotoxic waste management
·         Radioactive waste management
·         Others waste management


Europe and North America are the major market for medical waste treatment attributed to the stringent environmental and patient’s safety regulations in the region. Asia Pacific market for the medical waste treatment is growing at a significant rate. The strengthening healthcare infrastructure and increasing expenditure of Hospitals towards the waste management is driving the medical waste treatment market in Asia Pacific. 


Some of the major players operating in global medical waste management market include, Clean Harbors, Inc., Hawaii Bio-Waste Systems Inc. (HBW), Healthcare Environmental Services Group, Medclean Technologies Inc., Medasend Biomedical Inc., Miller Group, Republic Services Inc., Suez Environnement, Waste Management Inc., Aipura LIC, Stericycle Inc. and Gamma Waste Systems.
Posted by at No comments:
Labels: , ,

Wednesday, July 4, 2018

Feed Enzyme Market Insights by Geography, Competitive Landscape, Growth Drivers and Restraints

Feed Enzyme Market
Feed enzymes are enhancer that are incorporated in the animal feed during the manufacturing process to resolve the nutrient deficiencies in farm animals. Sometimes, animals face digestive troubles due to the consumption of anti-nutritional ingredients in the feed, which can be avoided by addition of feed enzymes. The feed enzymes are not only capable of withstanding acidic condition but also the heat generated during the pelleting process that breakdown starch, making the feed more digestible. 


With the global rise in demand of meat industry, and awareness among customers for the animal’s health and wellbeing, the considerable growth in the global feed enzyme market has been observed. Further, the need to opt for cheaper alternatives and to fulfill the globally growing demand of protein will drive the feed enzyme market in the coming years.


The global feed enzyme market is segmented on the basis of type, livestock, form, source. On the basis of type, phytase held the largest share in the global market in 2016; in comparison to protease, carbohydrase, lipase, and non-starch polysaccharides. However, protease is expected to witness significant growth during the forecast period (2017 – 2023) due to its low cost and its ability to reduce nitrogen emission. On the basis of livestock, poultry livestock was the largest contributor to the global market in 2016, as a result of the high demand in poultry meat.

Europe accounts the largest share in the global feed enzyme market in 2016, followed by North America, owing to the larger consumption of meat in the European countries. Besides, research in these countries to generate better performing enzymes will strengthen the global market. Different countries in Asia-Pacific such as; China, India, Japan, Australia with the larger population and changing food habits are expanding the feed enzyme market and is expected to be the fastest growing market during the forecast period. China expected to be the largest consumer of feed enzyme in the Asia-Pacific market.


Some of the key players in the global feed enzyme market are BASF SE, E. I. duPont de Nemours and Company, Adisseo France SAS, Rossari Biotech Ltd., Alltech Inc., Lesaffre & Cie, Associated British Foods plc, Koninklijke DSM N.V., Azelis S.A., Novus International Inc., and BIO-CAT.
Posted by at No comments:
Labels: , , ,

Tuesday, July 3, 2018

Healthcare EDI Market | Latest Tech used in Healthcare Industry

Healthcare EDI Market

Healthcare electronic data interchange (EDI) facilitates the exchange of healthcare data which is processed using computer software in a standardized format. Healthcare industry processes a large number of documents such as medical records of patients, healthcare claims, and reimbursement records. Healthcare EDI helps in the exchange of this information among healthcare institutions, healthcare professionals, and patients.


The use of healthcare EDI increases accuracy, improves productivity, helps in faster identification of errors, consumes less time, secures exchange of information and leads to ease of work for the healthcare providers, healthcare payers, and pharmacies. 


The key trend witnessed in the global healthcare EDI market is increasing number of research and development activities. With the rising prevalence of adoption of advanced technology in the healthcare market, the key players are investing more on the research and development on healthcare EDI, for the growth of the global healthcare EDI market. Additionally, increasing use of EDI in healthcare manufacturing and distribution industry and growing focus on integration platform as a service (IPAAS) are major trends observed in the global healthcare EDI market. The increase in outsourcing of EDI services and introduction of ICD-11 guidelines are creating ample opportunities for the growth of the global healthcare EDI market.

MARKET SEGMENTATION

By Component
  • Services
  • solutions
By Delivery Mode
  • Web & Cloud-based EDI
  • EDI VAN
  • Point-to-Point EDI
  • Mobile EDI
By Transaction Type
  • Claims Management
    • Claims Submission
    • Claim Status
    • Eligibility Verification
    • Payment Remittance
    • Referral Certification & Authorization
    • Claim Payments
    • Others
  • Healthcare Supply Chain
By End User
  • Healthcare Providers
  • Healthcare Payers
  • Medical Device & Pharmaceutical Industries
  • Pharmacies
Geographically, North America was the largest market for healthcare EDI in 2016, followed by Europe and Asia-Pacific. Some of the major factors driving the growth of the global healthcare EDI market in North America include, presence of a large number of healthcare EDI companies and rising demand for the innovative technological advancements in the healthcare market. Adoption of EDI services for supply chain management in hospitals and increased government efforts for improvement in reimbursement processes and healthcare coverage are driving the growth of the European healthcare EDI market. Asia-Pacific is expected to witness fastest growth during the period 2017 – 2023, due to the increasing healthcare expenditure by government, rising focus on research and development and technological investment.


Some of the key players in the global healthcare EDI market are GE Healthcare, Cognizant Technology Corporation, Cerner Corporation, Axway Software SA, Dell Technologies Inc., Synnex Corporation, McKesson Corporation, Allscripts Healthcare Solutions Inc., SSI Group, LLC, Comarch SA, Optum Inc., and Quality Systems Inc.
Posted by at No comments:
Labels: , , ,

Patient Engagement Solutions Market By Component | Application | Delivery Mode | End-User | Geography | Foresight by 2023

Patient Engagement Solutions Market

The global patient engagement solutions market is growing considerably, due to growing medical tourism and increasing cloud based models. During the forecast period, the software segment is expected to report the largest share, among all the components segments of the patient engagement solution market. Among the various delivery modes, the web based delivery segment leads the market, as it is cost effective and user friendly; however, the cloud based delivery segment is expected to grow with the fastest rate during the forecasted period. 

Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/patient-engagement-solutions-market/report-sample

 Among the various applications, the health management segment leads the global patient engagement solutions market. Based on therapeutics area, the chronic diseases segment leads the market in terms of size and is expected to grow with the fastest rate during the forecast period. Among the various end users, the providers segment led the market in 2014.

Global Patient Engagement Solutions Market Segmentation

 By Component
  • Software
    • Standalone software
    • Integrated software
  • Hardware
  • Services
By Application
  • Home Health Management 
  • Health Management
  • Social and Behavioral Management
  • Financial Health Management
By Delivery Mode
  • Web Based
  • On-Premise 
  • Cloud Based 
By Therapeutic Area
  • Chronic Diseases
    • Diabetes
    • Cardiovascular diseases
    • Obesity
    • Others
  • Women Health
  • Mental Health
  • Fitness
  • Others
Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/patient-engagement-solutions-market

Some of the factors driving the growth of the global patient engagement solutions market are growing geriatric population, increasing awareness of mobile health, increasing number of care organizations, high investment by payer and providers, and increasing prevalence of chronic diseases.

Geographically, North America is expected to dominate the global market in the coming years, due to growing geriatric population, implementation of Affordable Care Act, and increasing prevalence of chronic diseases. Asia is expected to be the fastest growing region, due to growing medical tourism and increasing healthcare awareness in the region. In addition, the Asian market of patient engagement solutions is growing due to increasing healthcare expenditure and increasing healthcare information technology adoption in the emerging countries, such as India and China.

Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=patient-engagement-solutions-market

Some of the companies operating in the global patient engagement solutions market are Mckesson Corporation, Athenahealth Inc., Medecision Inc., Cerner Corporation, Oneview healthcare, get Real Health, Welvu, Inc., Orion Health Ltd., Patientpoint, Lincor Solutions Ltd., EMMI Solutions LLC., Allscripts Healthcare Solutions Inc., Getwellnetwork Inc., and Phytel Inc.
Posted by at No comments:
Labels: ,

Clinical Laboratory Services Market Analysis Report with Future Demand Analysis till 2023

Clinical Laboratory Services Market 
The global clinical laboratory services market is growing significantly due to the advances in diagnostic techniques, increasing incidences of chronic diseases, and increasing geriatric population. Healthcare providers’ compliance for clinical diagnostic services is increasing due to the increasing demand for reducing hospitalization time and hospital readmission rates. This in turn propels the growth of the global clinical laboratory services market.

Several pharmaceutical companies investing huge capital for the development of advanced clinical laboratory devices is also supporting the demand for cost effective and efficient clinical laboratory services.





Clinical laboratory services have applications in various diagnostic tests, such as nucleic acid tests, pregnancy tests, HIV tests, and test for checking cholesterol level and the test have strong impact on the health outcome. Technological advancements have made diagnostic procedures easy, accurate, and less time consuming, and ultimately improving health outcomes.





Some of the factors driving the growth of the global clinical laboratory services market are advances in diagnostic techniques, increasing geriatric population, increasing healthcare providers’ compliance for diagnostic test and services, and increasing investment by big biopharmaceutical companies in the clinical laboratory services market.



Geographically, North America leads the global clinical laboratory services market due to high healthcare expenditure, high proportion of geriatric population, and high healthcare providers’ compliance for clinical laboratory services instruments. The high prevalence of chronic diseases also fuels the growth of the global clinical laboratory services market.



Asia-Pacific is the fastest growing region in the global clinical laboratory services market. The major reasons for the fastest growth in the region are increasing healthcare expenditure, increasing geriatric population, and improving healthcare infrastructure.






Some of the major players operating in the global clinical laboratory services market are ARUP Laboratories, Abbott Laboratories, Bio-Reference Laboratories, Charles River Laboratories, Bioscientia Healthcare, Genoptix Medical Laboratory, Healthscope Ltd, Laboratory Corporation Of America Holdings, Labco S.A., Quest Diagnostics Inc., Spectra Laboratories, Sonic Healthcare Limited, and Genoptix Medical Laboratory.
Posted by at No comments:
Labels: , ,
Subscribe to: Posts (Atom)